ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase I Study to Evaluate Safety, Tolerability, and Immunogenicity of a PIKA COVID-19 Vaccine in Healthy Individuals

Yisheng Biopharma (Singapore) Pte. Ltd. · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
covid-19-pandemic
covid-19 pandemic, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 837413
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.